Filing Details
- Accession Number:
- 0001209191-19-047330
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-23 16:58:53
- Reporting Period:
- 2019-08-21
- Accepted Time:
- 2019-08-23 16:58:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1492426 | Horizon Therapeutics Public Ltd Co | HZNP | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611468 | W. Paul Hoelscher | C/O Horizon Therapeutics Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2019-08-21 | 56,702 | $28.00 | 145,294 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2019-08-21 | 14,201 | $28.01 | 131,093 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2019-08-22 | 25,060 | $15.96 | 156,153 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2019-08-22 | 4,516 | $22.14 | 160,669 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Options (Right to Buy) | Disposition | 2019-08-22 | 25,060 | $0.00 | 25,060 | $15.96 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-08-22 | 4,516 | $0.00 | 4,516 | $22.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 64,940 | 2024-06-26 | No | 4 | M | Direct | |
| 271,484 | 2025-03-22 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2019.
- Includes 2,370 ordinary shares of the Issuer acquired by the reporting person on May 31, 2019 pursuant to an employee stock purchase program.
- 25% of the shares subject to the option vested and became exercisable on the first anniversary of June 27, 2014 (the date of grant), and the remaining shares vested in 36 equal monthly installments thereafter.
- 25% of the shares subject to the option vested and became exercisable on the first anniversary of March 23, 2015 (the date of grant), and the remaining shares vested in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
